Key Figures
| Staff | 150 |
| Products in development | 16 |
| Partnered products | 4 |
| Cash for operations | CHF 104.8 million
(plus $ 100 million upfront from Takeda) |
| Funding into | 2027
(assumes second ACI-35-related milestone payment of CHF25 million received in 2025 and no other milestones) |
| Debt | None |
| Shares outstanding | 99.4 million
(as of March 31, 2024; excluding treasury shares) |
| Potential total milestones from partners | CHF 4.3 billion |